VistaGen Therapeutics, Inc. Gains 27.1%
Mon, Feb 13, 2023 at 07:22 PM
VistaGen Therapeutics, Inc. (VTGN:NASDAQ) rocketted at $0.23, representing a gain of 27.1%. The stock got featured on our News Catalysts scanner on Tue, Feb 07, 2023 at 04:53 PM in the 'INVESTOR UPDATE' category. From Mon, Jan 30, 2023, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Mon, Feb 06, 2023 at $0.34 with a volume of 13M+.
About VistaGen Therapeutics, Inc. (VTGN:NASDAQ)
VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes product candidates for patients with central nervous system diseases. Its product AV-101 is currently being evaluated in a Phase 2 monotherapy study.
Top 10 Gainers:
- Vallon Pharmaceuticals Inc. (VLON:NASDAQ), 90.27%
- China Jo-Jo Drugstores, Inc. (CJJD:NASDAQ), 43.43%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 36.76%
- Ocular Therapeutix, Inc. (OCUL:NASDAQ), 35.14%
- LuxUrban Hotels Inc Com (LUXH:NASDAQ), 33.51%
- NGL Energy Partners LP (NGL:NYSE), 28.85%
- Fastly, Inc. (FSLY:NYSE), 27.66%
- VistaGen Therapeutics, Inc. (VTGN:NASDAQ), 27.1%
- Top Ships Inc. (TOPS:NASDAQ), 25.95%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 24.98%